基于“痰–瘀–虚”理论探讨神经病理性疼痛的发病机制及中医治疗
Discussion on the Pathogenesis and Chinese Medicine Treatment of Neuropathic Pain Based on theTheory of “Phlegm-Stasis-Deficiency”
DOI: 10.12677/tcm.2025.145323, PDF,   
作者: 罗 亮:乐山职业技术学院护理康养学院,四川 乐山;贵州中医药大学基础医学院,贵州 贵阳;王 豪:贵州中医药大学基础医学院,贵州 贵阳
关键词: 痰–瘀–虚神经病理性疼痛病机中医治疗Phlegm-Stasis-Deficiency Neuropathic Pain Pathogenesis Chinese Medicine Treatment
摘要: 神经病理性疼痛(NP)是一种由躯体感觉神经系统的病变或疾病引起的疼痛,在祖国医学中归类为“痛证”、“痹证”等范畴。尽管研究显示一些止痛类中药对改善神经病理性疼痛具有显著疗效,但在中医基础理论方面对其整体病机演变规律尚未得到广泛研究和共识。基于神经病理性疼痛的发病机制和临床特点,从“痰–瘀–虚”的角度探讨了神经病理性疼痛的发展演变过程,系统阐释了“痰–瘀–虚”的理论内涵以及与神经病理性疼痛之间的关系,深入了解其发病机制,并提出“祛痰通络,活血化瘀,补虚扶正”的中医药防治策略,为预防和治疗神经病理性疼痛提供了新的方向和思路。
Abstract: Neuropathic pain (NP) is a type of pain caused by lesions or diseases of the somatosensory nervous system, classified in traditional Chinese medicine as “pain syndrome” and “bi syndrome.” Although studies have shown significant therapeutic effects of certain analgesic traditional Chinese medicines in alleviating neuropathic pain, there is still limited research and consensus on the overall pathogenesis from the perspective of traditional Chinese medicine theory. Therefore, based on the pathogenesis and clinical characteristics of neuropathic pain, explores the developmental process of neuropathic pain from the perspective of the “phlegm-stasis-deficiency” theory. It systematically elucidates the theoretical implications of “phlegm-stasis-deficiency” and its relationship with neuropathic pain, providing a deeper understanding of its pathogenic mechanisms. The paper proposes a traditional Chinese medicine prevention and treatment strategy of “dispelling phlegm, promoting blood circulation, resolving stasis, nourishing deficiency, and strengthening the body,” offering new directions and insights for the prevention and treatment of neuropathic pain.
文章引用:罗亮, 王豪. 基于“痰–瘀–虚”理论探讨神经病理性疼痛的发病机制及中医治疗[J]. 中医学, 2025, 14(5): 2162-2168. https://doi.org/10.12677/tcm.2025.145323

参考文献

[1] Scholz, J., Finnerup, N.B., Attal, N., Aziz, Q., Baron, R., Bennett, M.I., et al. (2019) The IASP Classification of Chronic Pain for ICD-11: Chronic Neuropathic Pain. Pain, 160, 53-59. [Google Scholar] [CrossRef] [PubMed]
[2] Finnerup, N.B., Kuner, R. and Jensen, T.S. (2021) Neuropathic Pain: From Mechanisms to Treatment. Physiological Reviews, 101, 259-301. [Google Scholar] [CrossRef] [PubMed]
[3] Silva, R.L., Lopes, A.H., Guimarães, R.M. and Cunha, T.M. (2017) CXCL1/CXCR2 Signaling in Pathological Pain: Role in Peripheral and Central Sensitization. Neurobiology of Disease, 105, 109-116. [Google Scholar] [CrossRef] [PubMed]
[4] 赵禧, 施国善, 杨舒雯, 等. 基于“久痛入络”理论探讨神经病理性疼痛的中医诊疗思路[J]. 中国实验方剂学杂志, 2023, 29(13): 197-202.
[5] 林元杰, 吴耀持, 郭晟. 针灸治疗神经病理性疼痛的实验研究进展[J]. 西部中医药, 2018, 31(1): 138-142.
[6] 王振涛. 夹脊电针疗法联合自拟元胡止痛方治疗不完全性脊髓损伤后神经病理性疼痛疗效观察[J]. 现代中西医结合杂志, 2017, 26(28): 3107-3110.
[7] 剡建华, 朱琳, 赵美峰, 等. 芍药甘草汤加减联合氨酚羟考酮治疗神经性头痛疗效观察[J]. 现代中西医结合杂志, 2019, 28(1): 69-71+78.
[8] (汉)许慎, (宋)徐铉校. 说文解字[M]. 上海: 上海古籍出版社, 2021.
[9] 齐丽晶, 侯丽辉, 吴效科. 论痰浊与带下病[J]. 时珍国医国药, 2008(2): 497-499.
[10] 李霄, 李霖, 金鑫瑶, 等. 痰证理论源流及演变略论[J]. 中医杂志, 2020, 61(15): 1303-1306.
[11] 卢红蓉, 胡镜清. “瘀血”与“血瘀”辨析[J]. 中华中医药杂志, 2017, 32(2): 426-428.
[12] 孟锋, 王笑红, 卢红蓉. 血瘀证源流考[J]. 中国中医基础医学杂志, 2020, 26(5): 569-570+574.
[13] 袁林杰, 陈涛, 宋海祯, 等. “邪气盛则实,精气夺则虚”释疑[J]. 中华中医药杂志, 2013, 28(12): 3748-3749.
[14] 明·方隅. 医林绳墨[M]. 方榖, 王小岗, 贾晓凡, 校. 北京: 中医古籍出版社, 2012.
[15] (明)李中梓, 古典医籍编辑部. 医宗必读[M]. 北京: 中国中医药出版社, 2019.
[16] (元)朱震亨, 王英. 丹溪心法[M]. 北京: 中国医药科技出版社, 2020.
[17] Latremoliere, A. and Woolf, C.J. (2009) Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. The Journal of Pain, 10, 895-926. [Google Scholar] [CrossRef] [PubMed]
[18] Ji, R., Nackley, A., Huh, Y., Terrando, N. and Maixner, W. (2018) Neuroinflammation and Central Sensitization in Chronic and Widespread Pain. Anesthesiology, 129, 343-366. [Google Scholar] [CrossRef] [PubMed]
[19] Hoegh, M. (2022) Pain Science in Practice (Part 3): peripheral Sensitization. Journal of Orthopaedic & Sports Physical Therapy, 52, 303-306. [Google Scholar] [CrossRef] [PubMed]
[20] Fernandes, V., Sharma, D., Vaidya, S., P.A, S., Guan, Y., Kalia, K., et al. (2018) Cellular and Molecular Mechanisms Driving Neuropathic Pain: Recent Advancements and Challenges. Expert Opinion on Therapeutic Targets, 22, 131-142. [Google Scholar] [CrossRef] [PubMed]
[21] Inoue, K. and Tsuda, M. (2018) Microglia in Neuropathic Pain: Cellular and Molecular Mechanisms and Therapeutic Potential. Nature Reviews Neuroscience, 19, 138-152. [Google Scholar] [CrossRef] [PubMed]
[22] Alles, S.R.A. and Smith, P.A. (2018) Etiology and Pharmacology of Neuropathic Pain. Pharmacological Reviews, 70, 315-347. [Google Scholar] [CrossRef] [PubMed]
[23] Tsuda, M. (2019) Microglia-Mediated Regulation of Neuropathic Pain: Molecular and Cellular Mechanisms. Biological and Pharmaceutical Bulletin, 42, 1959-1968. [Google Scholar] [CrossRef] [PubMed]
[24] (唐)王冰. 黄帝内经素问[M]. 戴铭, 张淑贤, 林怡, 戴宇充, 校. 南宁: 广西科学技术出版社, 2016.
[25] 伍银平, 王佳, 赵星, 等. 李军教授从痰浊瘀毒论治三叉神经痛验案探析[J]. 四川中医, 2021, 39(12): 13-15.
[26] 高姗, 高进, 李铁, 等. 王富春针刺联合穴贴治疗顽固性三叉神经痛验案举隅[J]. 时珍国医国药, 2020, 31(8): 1990-1991.
[27] 邵翠, 齐维, 吴智兵. 中药治疗神经病理性疼痛的机理研究[J]. 世界科学技术-中医药现代化, 2015, 17(10): 2151-2155.
[28] 郭秋岩, 张彦琼, 林娜. 中医药干预神经病理性疼痛的作用机制研究进展[J]. 转化医学电子杂志, 2017, 4(11): 1-6.
[29] 刘珍珠, 刘修超, 佟常青, 等. 元气、原气、真气、正气的内涵及相互关系探析[J]. 中医杂志, 2022, 63(5): 401-406.
[30] Gui, Y., Li, A., Zhang, J., et al. (2018) α-Asarone Alleviated Chronic Constriction Injury-Induced Neuropathic Pain Through Inhibition of Spinal Endoplasmic Reticulum Stress in a Liver X Receptor-Dependent Manner. Anesthesia and Analgesia, 127, 775-783. [Google Scholar] [CrossRef
[31] Inceoglu, B., Bettaieb, A., Trindade Da Silva, C.A., et al. (2015) Endoplasmic Reticulum Stress in the Peripheral Nervous System Is a Significant Driver of Neuropathic Pain. Proceedings of the National Academy of Sciences of the United States of America, 112, 9082-9087. [Google Scholar] [CrossRef] [PubMed]
[32] 钟敏钰, 罗秀丽. 川芎嗪对紫杉醇诱发神经痛大鼠脊髓背角和背根神经节中NGF表达的影响[J]. 四川中医, 2016, 34(1): 59-62.
[33] 张美玉, 焦玥, 刘洋, 等. 川芎嗪对神经病理性疼痛模型大鼠的镇痛作用及对脑中枢敏化区氨基酸类神经递质含量的影响[J]. 中国药理学与毒理学杂志, 2018, 32(12): 921-929.
[34] 王依慰, 刘清珍, 陈春龙, 等. 白藜芦醇通过降低NF-κB p65乙酰化缓解大鼠神经病理性疼痛[J]. 中国药理学通报, 2016, 32(1): 89-93.
[35] 徐海龙, 齐敦益. 白藜芦醇通过抑制海马NF-κB减轻慢性坐骨神经挤压损伤大鼠神经病理性疼痛[J]. 临床和实验医学杂志, 2017, 16(1): 16-19.
[36] 王裕生, 李祺. 白藜芦醇缓解大鼠神经病理性疼痛的效果及机制[J]. 中国老年学杂志, 2017, 37(11): 2650-2652.
[37] 唐娟娟. 虎杖提取物对神经病理性疼痛模型大鼠的镇痛作用研究[J]. 中国现代药物应用, 2014, 8(7): 1-3.
[38] Zhou, J., Wang, J., Li, W., et al. (2017) Paeoniflorin Attenuates the Neuroinflammatory Response in a Rat Model of Chronic Constriction Injury. Molecular Medicine Reports, 15, 3179-3185. [Google Scholar] [CrossRef] [PubMed]
[39] Chen, P., Huang, N.Y., Pang, B., et al. (2023) Proteomic and Metabolomic Approaches Elucidate the Molecular Mechanism of Emodin Against Neuropathic Pain through Modulating the Gamma-Aminobutyric Acid (GABA)-ERGIC Pathway and PI3K/AKT/NF-κB Pathway. Phytotherapy Research: PTR, 37, 1883-1899. [Google Scholar] [CrossRef] [PubMed]
[40] 高枫, 尤浩军. 姜黄素对大鼠痛阈和脊髓组织TLR4表达的影响[J]. 基因组学与应用生物学, 2017, 36(8): 3341-3345.
[41] 程连芝, 周家梅, 马俊龙, 等. 延胡索乙素通过抑制p38 MAPK信号通路介导的小胶质细胞活化改善糖尿病大鼠神经病理性疼痛[J]. 中国中药杂志, 2022, 47(9): 2533-2540.
[42] 吴红艳, 师钰琪, 李佳豪, 等. 雷公藤红素对神经病理性疼痛模型小鼠的干预作用[J]. 中国实验方剂学杂志, 2020, 26(13): 97-103.
[43] 赵思思, 戴文玲, 刘吉华. 安络小皮伞醇提取物对神经病理性疼痛模型大鼠的镇痛作用研究[J]. 药物评价研究, 2016, 39(4): 553-558.
[44] 马俊龙, 唐何勇, 王帆竞, 等. 益气活血通络方对糖尿病神经病理性疼痛大鼠脊髓星形胶质细胞活性及JNK信号通路的影响[J]. 中华中医药杂志, 2021, 36(3): 1397-1401.
[45] 袁慧伦, 程凯, 陈前, 等. 基于ERK信号通路抑制星形胶质细胞活化探讨益气活血通络方对糖尿病大鼠神经病理性疼痛的作用[J]. 中国实验方剂学杂志, 2023, 29(23): 36-46.
[46] 周家梅, 胡光民, 程连芝, 等. 益气活血通络方通过抑制P2X7介导的脊髓小胶质细胞活化改善糖尿病大鼠神经病理性疼痛[J]. 安徽中医药大学学报, 2022, 41(2): 48-54.
[47] 王志福, 俞向梅, 龚德贵, 等. 身痛逐瘀汤对大鼠神经病理性疼痛及脊髓p38MAPK蛋白表达的影响[J]. 江西中医药大学学报, 2015, 27(2): 87-90.
[48] 戴帆, 钟义, 李琳, 等. 复方身痛逐瘀汤对脊神经结扎模型大鼠神经病理性疼痛影响[J]. 辽宁中医药大学学报, 2023, 25(6): 19-23.
[49] 郑冬明, 张娟, 王锐, 等. 芍药甘草汤有效组分对慢性坐骨神经结扎大鼠IL-6、IL-1β、TNF-α的影响[J]. 中华中医药学刊, 2013, 31(4): 801-803.
[50] 刘岩路, 王荣, 杨涛, 等. 黄芪桂枝五物汤对神经病理性疼痛大鼠脊髓CX3CR1表达的影响[J]. 现代中西医结合杂志, 2020, 29(7): 723-727.
[51] 吴红艳, 师钰琪, 朱春燕, 等. 乌头汤调控海马BDNF/Trk B通路以缓解神经病理性疼痛的痛共情绪症状[J]. 中国实验方剂学杂志, 2020, 26(1): 24-30.